Difference between revisions of "Part:BBa K1898100"
| (31 intermediate revisions by the same user not shown) | |||
| Line 3: | Line 3: | ||
<partinfo>BBa_K1898100 short</partinfo> | <partinfo>BBa_K1898100 short</partinfo> | ||
| − | This DNA codes for | + | This DNA codes for CH25H, also known as cholesterol 25-hydroxylase, which catalyzes the formation of 25 hydroxycholesterol (25HC) from cholesterol. |
===Usage and Biology=== | ===Usage and Biology=== | ||
| − | 25 hydroxycholesterol (25 HC) has been reported to have a range of effects on the immune system, including the suppression of production of IgA by B cells and inducing the migration of human peripheral blood monocytes [1]. 25 HC is also found to be able to reverse protein aggregation and restore solubility to the proteins [2]. In our project, we aim to deliver CH25H to the lens, where 25 HC will be produced and reverse aggregated lens protein. Aged-induced cataracts occur when lens proteins get oxidized and clump together. | + | 25 hydroxycholesterol (25 HC) has been reported to have a range of effects on the immune system, including the suppression of production of IgA by B cells and inducing the migration of human peripheral blood monocytes [1]. 25 HC is also found to be able to reverse protein aggregation and restore solubility to the proteins [2]. In our project, we aim to deliver CH25H to the lens, where 25 HC will be produced and reverse aggregated lens protein. Aged-induced cataracts occur when lens proteins get oxidized and clump together. The increase of 25HC in the lens will help to treat cataracts. |
[1] Diczfalusy, U. (2013). On the formation and possible biological role of 25-hydroxycholesterol. Biochimie, 95(3), 455-460. doi:10.1016/j.biochi.2012.06.016 | [1] Diczfalusy, U. (2013). On the formation and possible biological role of 25-hydroxycholesterol. Biochimie, 95(3), 455-460. doi:10.1016/j.biochi.2012.06.016 | ||
| + | |||
[2] Makley, L. N., McMenimen, K. A., DeVree, B. T., Goldman, J. W., McGlasson, B. N., Rajagopal, P., Dunyak, B.M., McQuade, T.J., Thompson, A.D., Sunahara, R., Klevit, R.E., Andley, U.P., and Gestwicki, J.E. (2015). Pharmacological chaperone for α-crystallin partially restores transparency in cataract models. Science, 350(6261), 674-677. | [2] Makley, L. N., McMenimen, K. A., DeVree, B. T., Goldman, J. W., McGlasson, B. N., Rajagopal, P., Dunyak, B.M., McQuade, T.J., Thompson, A.D., Sunahara, R., Klevit, R.E., Andley, U.P., and Gestwicki, J.E. (2015). Pharmacological chaperone for α-crystallin partially restores transparency in cataract models. Science, 350(6261), 674-677. | ||
| Line 21: | Line 22: | ||
<partinfo>BBa_K1898100 parameters</partinfo> | <partinfo>BBa_K1898100 parameters</partinfo> | ||
<!-- --> | <!-- --> | ||
| + | |||
| + | |||
| + | |||
| + | ==Gel Pictures== | ||
| + | We designed primers to remove a stop codon and to move CH25H cDNA into iGEM BioBrick. PCR was set up and the gel picture is shown below. The expected size for CH25H PCR check is ~1.1kb. The bands boxed in red are the correct bands. | ||
| + | |||
| + | https://static.igem.org/mediawiki/parts/0/0e/Ch25h_gel.png | ||
| + | |||
| + | ==Sequencing== | ||
| + | |||
| + | CH25H was sent to sequencing and the result shows that the CH25H sequencing result is correct (with no stop codon): | ||
| + | |||
| + | https://static.igem.org/mediawiki/parts/7/7e/Ch25h_sequence.png | ||
| + | |||
| + | The four cutting sites are highlighted in red and CH25H is highlighted in orange | ||
Latest revision as of 02:59, 20 October 2016
ch25h, cholesterol 25 hydroxylase
This DNA codes for CH25H, also known as cholesterol 25-hydroxylase, which catalyzes the formation of 25 hydroxycholesterol (25HC) from cholesterol.
Usage and Biology
25 hydroxycholesterol (25 HC) has been reported to have a range of effects on the immune system, including the suppression of production of IgA by B cells and inducing the migration of human peripheral blood monocytes [1]. 25 HC is also found to be able to reverse protein aggregation and restore solubility to the proteins [2]. In our project, we aim to deliver CH25H to the lens, where 25 HC will be produced and reverse aggregated lens protein. Aged-induced cataracts occur when lens proteins get oxidized and clump together. The increase of 25HC in the lens will help to treat cataracts.
[1] Diczfalusy, U. (2013). On the formation and possible biological role of 25-hydroxycholesterol. Biochimie, 95(3), 455-460. doi:10.1016/j.biochi.2012.06.016
[2] Makley, L. N., McMenimen, K. A., DeVree, B. T., Goldman, J. W., McGlasson, B. N., Rajagopal, P., Dunyak, B.M., McQuade, T.J., Thompson, A.D., Sunahara, R., Klevit, R.E., Andley, U.P., and Gestwicki, J.E. (2015). Pharmacological chaperone for α-crystallin partially restores transparency in cataract models. Science, 350(6261), 674-677.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Gel Pictures
We designed primers to remove a stop codon and to move CH25H cDNA into iGEM BioBrick. PCR was set up and the gel picture is shown below. The expected size for CH25H PCR check is ~1.1kb. The bands boxed in red are the correct bands.
Sequencing
CH25H was sent to sequencing and the result shows that the CH25H sequencing result is correct (with no stop codon):
The four cutting sites are highlighted in red and CH25H is highlighted in orange